Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol.

Smith SC Jr, Grundy SM.

J Am Coll Cardiol. 2014 Aug 12;64(6):601-12. doi: 10.1016/j.jacc.2014.06.1159. Review.

2.

A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps.

Lopez-Jimenez F, Simha V, Thomas RJ, Allison TG, Basu A, Fernandes R, Hurst RT, Kopecky SL, Kullo IJ, Mulvagh SL, Thompson WG, Trejo-Gutierrez JF, Wright RS.

Mayo Clin Proc. 2014 Sep;89(9):1257-78. doi: 10.1016/j.mayocp.2014.06.016. Epub 2014 Aug 12.

PMID:
25131697
3.

Recent Update to the US Cholesterol Treatment Guidelines: A Comparison With International Guidelines.

Nayor M, Vasan RS.

Circulation. 2016 May 3;133(18):1795-806. doi: 10.1161/CIRCULATIONAHA.116.021407. Review.

PMID:
27143546
4.

Cholesterol treatment and changes in guidelines in an academic medical practice.

Schoen MW, Salas J, Scherrer JF, Buckhold FR.

Am J Med. 2015 Apr;128(4):403-9. doi: 10.1016/j.amjmed.2014.10.039. Epub 2014 Nov 18.

PMID:
25460526
5.

2013 ACC/AHA cholesterol treatment guideline: what was done well and what could be done better.

Martin SS, Abd TT, Jones SR, Michos ED, Blumenthal RS, Blaha MJ.

J Am Coll Cardiol. 2014 Jun 24;63(24):2674-8. doi: 10.1016/j.jacc.2014.02.578. Epub 2014 Mar 26. Review.

6.

Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.

Yeboah J, Polonsky TS, Young R, McClelland RL, Delaney JC, Dawood F, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC Jr, Psaty BM, Greenland P, Herrington DM.

Circulation. 2015 Sep 8;132(10):916-22. doi: 10.1161/CIRCULATIONAHA.115.016846. Epub 2015 Jul 29.

7.

2013 ACC/AHA cholesterol guideline for reducing cardiovascular risk: what is so controversial?

Robinson JG.

Curr Atheroscler Rep. 2014 Jun;16(6):413. doi: 10.1007/s11883-014-0413-5. Review.

PMID:
24671669
8.

Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations.

Zupec JF, Marrs JC, Saseen JJ.

Ann Pharmacother. 2016 Jan;50(1):17-21. doi: 10.1177/1060028015608199. Epub 2015 Sep 28.

PMID:
26416950
9.
10.

Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.

Maddox TM, Borden WB, Tang F, Virani SS, Oetgen WJ, Mullen JB, Chan PS, Casale PN, Douglas PS, Masoudi FA, Farmer SA, Rumsfeld JS.

J Am Coll Cardiol. 2014 Dec 2;64(21):2183-92. doi: 10.1016/j.jacc.2014.08.041. Epub 2014 Nov 19.

11.
12.

The 2013 American College of Cardiology/American Heart Association guidelines on treating blood cholesterol and assessing cardiovascular risk: a busy practitioner's guide.

Gupta A, Smith DA.

Endocrinol Metab Clin North Am. 2014 Dec;43(4):869-92. doi: 10.1016/j.ecl.2014.08.006. Review.

PMID:
25432387
13.

The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011.

Ray KK, Kastelein JJ, Boekholdt SM, Nicholls SJ, Khaw KT, Ballantyne CM, Catapano AL, Reiner Ž, Lüscher TF.

Eur Heart J. 2014 Apr;35(15):960-8. doi: 10.1093/eurheartj/ehu107. Epub 2014 Mar 17.

PMID:
24639424
14.

Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.

Stone NJ, Robinson JG, Lichtenstein AH, Goff DC Jr, Lloyd-Jones DM, Smith SC Jr, Blum C, Schwartz JS; 2013 ACC/AHA Cholesterol Guideline Panel..

Ann Intern Med. 2014 Mar 4;160(5):339-43. doi: 10.7326/M14-0126.

PMID:
24474185
15.

Primary prevention of atherosclerotic cardiovascular disease: controversies and clinical considerations.

Newsom LC.

Ann Pharmacother. 2015 Apr;49(4):484-93. doi: 10.1177/1060028014564181. Epub 2014 Dec 19. Review.

PMID:
25527102
17.

Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).

Yeboah J, Sillau S, Delaney JC, Blaha MJ, Michos ED, Young R, Qureshi WT, McClelland R, Burke GL, Psaty BM, Herrington DM.

Am Heart J. 2015 Mar;169(3):387-395.e3. doi: 10.1016/j.ahj.2014.12.018. Epub 2015 Jan 6.

18.

The 2013 ACC/AHA guidelines on the treatment of blood cholesterol: questions, questions, questions.

Ginsberg HN.

Circ Res. 2014 Feb 28;114(5):761-4. doi: 10.1161/CIRCRESAHA.114.303398. No abstract available.

19.

2013 ACC/AHA cholesterol treatment guideline: Paradigm shifts in managing atherosclerotic cardiovascular disease risk.

Finkel JB, Duffy D.

Trends Cardiovasc Med. 2015 May;25(4):340-7. doi: 10.1016/j.tcm.2014.10.015. Epub 2014 Oct 28. Review.

PMID:
25435519
20.

Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.

Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, Ikram MA, Stricker BH, Hofman A, Franco OH.

JAMA. 2014 Apr 9;311(14):1416-23. doi: 10.1001/jama.2014.2632.

PMID:
24681960

Supplemental Content

Support Center